Technical420 Site Search

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces that its subsidiary, Natural Ventures PR LLC (“Natural Ventures”), has entered into an agreement to purchase (the “Acquisition”) three cannabis dispensary operations (the “Dispensaries”) in Puerto Rico from Caribbean Green LLC (“Caribbean Green”) in exchange for $1.3 million USD…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has completed the installation, permitting, and testing phase of its QuickStrip™ oral thin strip production equipment. The Company has completed the previously announced commercialization strategy, and has begun accepting…

Latin America is one of the most exciting emerging cannabis markets and this is a trend that has been gaining traction. During the last year, we have seen increased interest in the Latin American cannabis market and have been highly focused on this opportunity. One of the main reasons for…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is pleased to announce that it has completed its previously announced transaction  to acquire a controlling interest in GSRX Industries Inc. (“GSRX”) (OTCQB: GSRX) (the “Acquisition”), pursuant to which  the Company has acquired from certain former GSRX shareholders (the…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA), announces that it will begin to manufacture, package and distribute its own line of tobacco-free smokeless cannabis and hemp derived chew with initial launch and commercialization in the United States, Puerto Rico and Canada. The Company continues to build out a unique portfolio of…

During the last quarter, the cannabis sector has been under considerable pressure and we have been closely following this trend. Although companies continue to execute, the sector has been trading lower on average and we expect this trend to reverse in the coming weeks. The recent decline has brought valuations…

During the last year, we have seen a significant increase in the number of companies that are focused on the international cannabis opportunity and this is a trend that our readers need to be aware of. Earlier this week, we published an article that highlights 5 leading Israeli cannabis companies…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), announces the addition of Chief Science Officer, Dr. Joshua Hartsel, a leader in the Research and Development of cannabis and hemp extraction technologies across the industry. Dr. Hartsel’s experience in the cannabis industry has a special focus…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF), announces it has received approval from the State of Michigan to commence construction of its Hemp Processing facility (“Facility”). With this approval, the Company will continue to focus on obtaining assets that allow Chemesis’ to vertically integrate its operations in the state. Chemesis…

Chemesis International Inc. (CSE: CSI) (OTC: CADMF), announces unaudited fiscal Q3 Financial Statements for the three months ending March 31, 2019. In this quarter; the Company reported Revenue of $3,762,139, a 33% increase over the previous quarter, with Gross Profit of $1,113,903. the Company closed the acquisition of La Finca…